SEC Form 4 · accession 0001070081-17-000023
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Rothera
Officer — Chief Commercial Officer
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 3, 2017 | A | 9,600 | $0.00 | A | 22,523 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F3 | $11.23 | Jan 3, 2017 | A | 56,000 | A | — | Jan 2, 2027 | Common Stock | 56,000 | 56,000 | D |
Explanation of responses
- F1Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018.
- F2Includes 1,707 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2016.
- F3This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.